233 related articles for article (PubMed ID: 21169530)
1. Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis.
Kim JY; Kim SY
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1742-7. PubMed ID: 21169530
[TBL] [Abstract][Full Text] [Related]
2. Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis.
Ermis SS; Cetinkaya Z; Kiyici H; Inan UU; Ozturk F
Curr Eye Res; 2007 Apr; 32(4):337-44. PubMed ID: 17453955
[TBL] [Abstract][Full Text] [Related]
3. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
Am J Ophthalmol; 2005 Sep; 140(3):497-504. PubMed ID: 16083841
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of intravitreal piperacillin/tazobactam in rabbits with experimental Staphylococcus epidermidis endophthalmitis: a comparison with vancomycin.
Ozkiriş A; Evereklioglu C; Eşel D; Akgün H; Erkiliç K
Ophthalmic Res; 2005; 37(3):168-74. PubMed ID: 15942265
[TBL] [Abstract][Full Text] [Related]
5. Effect of intravitreal triamcinolone acetonide in the treatment of experimental Staphylococcus epidermidis endophthalmitis.
Hosseini H; Mehryar M; Eghtedari M; Ahmadi F; Nowroozizadeh S
Curr Eye Res; 2009 Feb; 34(2):145-51. PubMed ID: 19219686
[TBL] [Abstract][Full Text] [Related]
6. Treatment of experimental Bacillus cereus endophthalmitis using intravitreal moxifloxacin with or without dexamethasone.
Sakalar YB; Ozekinci S; Celen MK
J Ocul Pharmacol Ther; 2011 Dec; 27(6):593-8. PubMed ID: 21834669
[TBL] [Abstract][Full Text] [Related]
7. Intravenous imipenem prophylaxis in experimental endophthalmitis.
Miño de Kaspar H; Engelbert M; Thiel M; Grasbon T; Ta CN; Klauss V; Kampik A
Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):557-64. PubMed ID: 12136287
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Staphylococcus epidermidis endophthalmitis with intravitreal moxifloxacin in a rabbit model.
Ermis SS; Cetinkaya Z; Kiyici H; Ozturk F
Tohoku J Exp Med; 2005 Mar; 205(3):223-9. PubMed ID: 15718814
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antifungal efficacies of moxifloxacin, liposomal amphotericin B, and combination treatment in experimental Candida albicans endophthalmitis in rabbits.
Deren YT; Ozdek S; Kalkanci A; Akyürek N; Hasanreisoğlu B
Can J Microbiol; 2010 Jan; 56(1):1-7. PubMed ID: 20130687
[TBL] [Abstract][Full Text] [Related]
10. Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model.
Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
Am J Ophthalmol; 2004 Jul; 138(1):33-7. PubMed ID: 15234279
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal taurolidine against experimental Staphylococcus epidermidis endophthalmitis in rabbits.
Oguz H; Zeyrek FY; Ozardali I; Oguz E; Gurkan T
Curr Eye Res; 2004 Apr; 28(4):225-32. PubMed ID: 15259291
[TBL] [Abstract][Full Text] [Related]
12. Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment.
Bucher RS; Hall E; Reed DM; Richards JE; Johnson MW; Zacks DN
Arch Ophthalmol; 2005 May; 123(5):649-53. PubMed ID: 15883284
[TBL] [Abstract][Full Text] [Related]
13. Systemic Moxifloxacin in Streptococcus viridans Endophthalmitis.
Nam KY; Lee SJ; Kim JY
Ocul Immunol Inflamm; 2019; 27(1):155-161. PubMed ID: 28981383
[TBL] [Abstract][Full Text] [Related]
14. Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental endophthalmitis.
De Kaspar HM; Ta CN; Engelbert M; Mette M; Thiel M; Kampik A
Retina; 2008 Feb; 28(2):326-32. PubMed ID: 18301039
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate reduces the complications of endophthalmitis resulting from intravitreal injection compared with dexamethasone in a rabbit model.
Deng SX; Penland S; Gupta S; Fiscella R; Edward DP; Tessler HH; Goldstein DA
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1516-21. PubMed ID: 16565387
[TBL] [Abstract][Full Text] [Related]
16. Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model.
Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
J Ocul Pharmacol Ther; 2008 Feb; 24(1):1-7. PubMed ID: 18370872
[TBL] [Abstract][Full Text] [Related]
17. Experimental intracameral injection of vancomycin microparticles in rabbits.
Kodjikian L; Couprie J; Hachicha W; Timour Q; Devouassoux M; Builles N; Hartmann D; Fessi H
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4125-32. PubMed ID: 20335605
[TBL] [Abstract][Full Text] [Related]
18. Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin.
Deramo VA; Lai JC; Fastenberg DM; Udell IJ
Am J Ophthalmol; 2006 Nov; 142(5):721-5. PubMed ID: 16989762
[TBL] [Abstract][Full Text] [Related]
19. A preliminary study to treat severe endophthalmitis via a foldable capsular vitreous body with sustained levofloxacin release in rabbits.
Wang T; Huang X; Gao Q; Feng L; Xie Z; Jiang Z; Liu Y; Li Y; Lin X; Lin J
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):804-12. PubMed ID: 23258145
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal trovafloxacin against experimental Staphylococcus epidermidis endophthalmitis.
Karaküçük S; Mirza E; Sümerkan B; Okten T
Ophthalmic Res; 2000; 32(2-3):126-31. PubMed ID: 10754446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
